These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9305851

  • 1. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
    Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ.
    J Biol Chem; 1997 Sep 26; 272(39):24101-4. PubMed ID: 9305851
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S, Johnson DE.
    Biochemistry; 2002 Jul 30; 41(30):9485-95. PubMed ID: 12135371
    [Abstract] [Full Text] [Related]

  • 9. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites.
    Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, Gietz RD, Greenberg AH.
    J Biol Chem; 2000 Jan 14; 275(2):1439-48. PubMed ID: 10625696
    [Abstract] [Full Text] [Related]

  • 10. Structural biology of the Bcl-2 family of proteins.
    Petros AM, Olejniczak ET, Fesik SW.
    Biochim Biophys Acta; 2004 Mar 01; 1644(2-3):83-94. PubMed ID: 14996493
    [Abstract] [Full Text] [Related]

  • 11. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB, Fesik SW.
    Protein Sci; 2000 Dec 01; 9(12):2528-34. PubMed ID: 11206074
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of a novel phosphorylation site, Ser-170, as a regulator of bad pro-apoptotic activity.
    Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R, Duronio V.
    J Biol Chem; 2002 Feb 22; 277(8):6399-405. PubMed ID: 11717309
    [Abstract] [Full Text] [Related]

  • 18. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
    Yasuda M, Chinnadurai G.
    Oncogene; 2000 May 04; 19(19):2363-7. PubMed ID: 10822388
    [Abstract] [Full Text] [Related]

  • 19. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
    Moroy G, Martin E, Dejaegere A, Stote RH.
    J Biol Chem; 2009 Jun 26; 284(26):17499-511. PubMed ID: 19293158
    [Abstract] [Full Text] [Related]

  • 20. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL.
    Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J.
    Nat Cell Biol; 2001 Feb 26; 3(2):173-82. PubMed ID: 11175750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.